U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06884085) titled 'A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B' on March 13.
Brief Summary: Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-227 in healthy subjects.
Study Start Date: Feb. 18
Study Type: INTERVENTIONAL
Condition:
Primary Hypertension
Intervention:
DRUG: Co-administration of AD-227A and AD-227B
Co-administration of AD-227A 1Tab. and AD-227B 1Tab., Per Oral
DRUG: Administration of AD-227A
Administration of AD-227A 1Tab., Per Oral
Recruitment Status: RECRUITING
Sponsor: Addpharma Inc.
Published by HT Digital Co...